1. Home
  2. GIB vs BAX Comparison

GIB vs BAX Comparison

Compare GIB & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CGI Inc.

GIB

CGI Inc.

N/A

Current Price

$73.50

Market Cap

12.8B

ML Signal

N/A

Logo Baxter International Inc.

BAX

Baxter International Inc.

N/A

Current Price

$26.74

Market Cap

13.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GIB
BAX
Founded
1976
1931
Country
Canada
United States
Employees
N/A
37500
Industry
Professional Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.8B
13.9B
IPO Year
1999
1994

Fundamental Metrics

Financial Performance
Metric
GIB
BAX
Price
$73.50
$26.74
Analyst Decision
Hold
Hold
Analyst Count
3
9
Target Price
$112.00
$21.00
AVG Volume (30 Days)
470.7K
7.6M
Earning Date
04-29-2026
04-30-2026
Dividend Yield
0.70%
0.24%
EPS Growth
N/A
N/A
EPS
N/A
0.21
Revenue
N/A
$11,244,000,000.00
Revenue This Year
$8.33
$1.96
Revenue Next Year
$2.96
$2.22
P/E Ratio
$13.59
$128.79
Revenue Growth
N/A
5.72
52 Week Low
$59.63
$15.73
52 Week High
$97.55
$30.00

Technical Indicators

Market Signals
Indicator
GIB
BAX
Relative Strength Index (RSI) 57.13 61.41
Support Level $70.05 $18.58
Resistance Level $75.34 $30.00
Average True Range (ATR) 2.26 1.18
MACD 0.01 -0.07
Stochastic Oscillator 58.68 50.35

Price Performance

Historical Comparison
GIB
BAX

About GIB CGI Inc.

CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.

About BAX Baxter International Inc.

Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

Share on Social Networks: